Since GSH is essential to neutralize ROS, its reduction could contribute to higher accumulation of O2•− and H2O2 (mainly via XO or NADPH oxidase production), and together with the increased GSSG content, could explain the marked increase of lipid damage (MDA) also observed in PMNs from NDD-CKD patients. This evidence concerns the gene FMO5 and chronic kidney disease.